fda warning letter bpc-157 unapproved new drug FDA Issues Warning Letters to 80 Retailers for FDA panel narrowly backs unapproved

It does not cause photosensitivity (unlike retinoids), does not thin the skin (unlike corticosteroids), and does not require a tolerance-building period

1 The prevalence is 70% in Kenyan school children, 80% in East Indian preschool-aged children, and 70% in East Indian adults

Insert the needle through the stopper, invert the vial, and pull back the plunger to the desired volume

For use by professionals only

Collaboration in general is seen as necessary for ensuring downstream providers are able to achieve clinical integration with PPS, particularly since many downstream providers may be engaged with multiple PPS